ArticleOncotarget2016

TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors.

Amit Dipak Amin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.